- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02274844
Improving Medication Adherence in the Alabama Black Belt
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Improving medication adherence is one of the greatest challenges in modern medicine. Despite decades of research on the topic, as many as half of patients with chronic diseases are not taking medications as recommended, and costs of nonadherence have been estimated at $290 billion annually. One reason for this persistent finding could be that interventions rarely acknowledge medications within the larger context of the lived experience of illness. Drawing on hundreds of patient interviews, Corbin and Strauss showed that chronic illness is a fundamentally destabilizing influence that forces us to confront the potential limitations of our "new", chronically ill self. Accepting our illness may be a crucial step in embracing medication adherence and other self-management behaviors as ways to restore balance following this disruption. The Corbin and Strauss framework is not often used to develop and test interventions to improve medication adherence, and this is the central objective of this proposal.
Medication adherence is especially critical in regions like rural Alabama, where residents have among the worst health outcomes in the US. Rates of cardiovascular mortality, diabetes and obesity are very high, but resources are scarce and the area's predominately black residents have deep-seated mistrust of the healthcare system (the region includes Tuskegee, site of the infamous syphilis study). This project was designed in collaboration with our community member partners and builds on a 5-year partnership of community-engaged research on diabetes peer coaching interventions and our experience with peer storytelling. The investigators will test the hypothesis that an intervention designed within the Corbin and Strauss framework can improve adherence and health outcomes compared to usual care. Our Aims are:
Aim 1: With our community partners, using qualitative research methods, build on already developed culturally tailored education material to develop the medication adherence intervention. The intervention will consist of educational DVDs with integrated storytelling about how community members accepted their disease and overcame barriers to medication adherence, plus one-on-one telephonic peer coaching. Activities include conducting focus groups with patients; creating the DVDs and the coaching intervention protocol; training peer coaches; and pilot testing.
Aim 2: Conduct a randomized controlled trial with 500 individuals with type 2 diabetes and medication nonadherence. The trial will compare the effect of usual care and the intervention on medication adherence and physiologic risk factors including A1c, blood pressure and low density lipoprotein cholesterol (primary outcomes), and quality of life and self-efficacy (secondary outcomes).
This innovative approach would be a major shift in how patients are helped in under resourced areas living with chronic diseases commit to taking medications, improving health and eventually reducing health disparities.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Alabama
-
Birmingham, Alabama, Stany Zjednoczone, 35210
- Univeristy of Alabama at Birmingham
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- adults
- type 2 diabetes
- taking medications for diabetes
- medication non adherent
Exclusion Criteria:
- nursing home residence
- plans to move away in the next year
- advanced illnesses such as hemodialysis, cancer or dementia
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Peer Coaching
The intervention participants will receive the Living Well with Diabetes Program.
The program will consist of educational DVDs with integrated storytelling about how community members accepted their disease and overcame barriers to medication adherence, plus one-on-one telephonic peer coaching.
|
The intervention participants will receive the Living Well with Diabetes Program.
The program will consist of educational DVDs with integrated storytelling about how community members accepted their disease and overcame barriers to medication adherence, plus one-on-one telephonic peer coaching
|
Brak interwencji: Usual Care
At enrollment, the investigators will provide an educational DVD on general health and wellness topics including vaccination, cancer screening, osteoporosis and other topics not related to diabetes care.
There will be no peer storytelling on these DVDs.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change in Self Reported Medication Adherence
Ramy czasowe: Baseline, 6 months
|
Patient-reported adherence to medications as a medication adherence score, from 0-3, where a higher score indicates worse adherence.
|
Baseline, 6 months
|
Change in Percentage of HbA1c
Ramy czasowe: Baseline, 6 months
|
Hemoglobin A1c test to identify the average amount of glucose (sugar) present in a patient's blood.
|
Baseline, 6 months
|
Change in Blood Pressure
Ramy czasowe: Baseline, 6 months
|
2 BP measures were taken 1 minute apart using a LifeSource UA-789 digital blood pressure monitor.
|
Baseline, 6 months
|
Change in Low-Density Lipoprotein (LDL) Cholesterol
Ramy czasowe: Baseline, 6 months
|
Finger stick, spectrophotometer to measure cholesterol level.
|
Baseline, 6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change in Quality of Life as Assessed With the Short Form 12- Mental Component
Ramy czasowe: Baseline, 6 months
|
Short Form-12 Mental Component and Physical Component Summary scores range from 0-100; higher scores indicate greater quality of life.
|
Baseline, 6 months
|
Change in Quality of Life as Assessed With the Short Form-12- Physical Component
Ramy czasowe: Baseline, 6 months
|
Short Form-12 Mental Component and Physical Component Summary scores range from 0-100; higher scores indicate greater quality of life.
|
Baseline, 6 months
|
Change in Medication Use Self-efficacy Score as Measured by SEAMS Scale and the Perceived Diabetes Self-Management Scale, Which is Associated With A1c
Ramy czasowe: Baseline, 6 months
|
Medication use self-efficacy scores for range from 13-39; higher scores indicate higher levels of self-efficacy for medication adherence.
|
Baseline, 6 months
|
Change in Diabetes-Specific Quality of Life
Ramy czasowe: Baseline, 6 months
|
Diabetes specific quality of life will be assessed using the validated Diabetes Distress Scale.The DDS is a 17-item instrument that measures diabetes-related emotional distress.
Participants rate the degree to which each item is problematic for them on a 6-point Likert scale, from 1 (no problem) to 6 (serious problem).
A score of 3 or greater = moderate distress.
|
Baseline, 6 months
|
Number of Physician Office Visits 6 Months
Ramy czasowe: 6 months
|
6 months
|
|
Number of Hospital Stays at 6 Months
Ramy czasowe: 6 months
|
6 months
|
|
Number of Emergency Visits at 6 Months
Ramy czasowe: 6 months
|
6 months
|
|
Change in Diabetes Medication Counts
Ramy czasowe: Baseline, 6 months
|
Change in number of diabetes medications.
|
Baseline, 6 months
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change in Medication Beliefs- Harm (Beliefs That Medications Are Harmful)
Ramy czasowe: Baseline, 6 months
|
Beliefs about medications questionnaire scores range from 5-25; higher scores indicate stronger beliefs.
|
Baseline, 6 months
|
Change in Medication Beliefs- Overuse (Concerns About the Way Doctors Use Medications)
Ramy czasowe: Baseline, 6 months
|
Beliefs about medications questionnaire scores range from 5-25; higher scores indicate stronger beliefs.
|
Baseline, 6 months
|
Change in Medication Beliefs-Necessity (Beliefs About the Necessity of Medications)
Ramy czasowe: Baseline, 6 months
|
Beliefs about medications questionnaire scores range from 5-25; higher scores indicate stronger beliefs.
|
Baseline, 6 months
|
Change in Medication Beliefs- Concerns (Concerns About the Negative Effects of Medications)
Ramy czasowe: Baseline, 6 months
|
Beliefs about medications questionnaire scores range from 5-25; higher scores indicate stronger beliefs.
|
Baseline, 6 months
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Monika M Safford, MD, Weill Medical College of Cornell University
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Inne numery identyfikacyjne badania
- PCORI-R-AD-1306-03565
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Cukrzyca
-
National Center for Research Resources (NCRR)Northwestern UniversityZakończonyMoczówka prosta | Diabetes Insipidus, NeurohypophysealStany Zjednoczone
-
Bruce A. BuckinghamZakończonyCukrzyca typu 1 | Cukrzyca autoimmunologiczna | Cukrzyca młodzieńcza | Cukrzyca, Mellitus, Typ 1Stany Zjednoczone
-
Ferring PharmaceuticalsZakończonyCentralna moczówka prostaJaponia
-
Universitair Ziekenhuis BrusselZakończonyNefrogenna moczówka prostaBelgia
-
Leiden University Medical CenterZakończonyGruczolak przysadki | Guz przysadki | Diabetes Insipidus Cranial Type | Dokrewny; NiedobórHolandia
-
National Center for Research Resources (NCRR)Northwestern UniversityZakończonyDiabetes Insipidus, nefrogenny
-
Emory UniversityZakończony
-
Elizabeth Austen LawsonJeszcze nie rekrutacjaCentralna moczówka prostaStany Zjednoczone
-
University of Colorado, DenverUniversity of AarhusZakończonyNefrogenna moczówka prostaStany Zjednoczone, Dania
-
Lady Davis InstituteZakończonyZastosowanie litu, moczówka prosta nefrogennaKanada
Badania kliniczne na Living Well with Diabetes Program
-
University of California, San FranciscoUniversity of California, Davis; University of California, Merced; California... i inni współpracownicyRekrutacyjnyCOVID-19 | Dobre samopoczucie, psychologiczneStany Zjednoczone
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Rejestracja na zaproszenieChoroby nerekStany Zjednoczone
-
The Hong Kong Polytechnic UniversityZakończonyUrządzenie nieskuteczneHongkong
-
Dana-Farber Cancer InstituteWycofaneGlejak niskiego stopnia | Przetrwanie | Obciążenie związane z opiekąStany Zjednoczone
-
Susan LutgendorfUniversity of Miami; University of Iowa; University of WashingtonRekrutacyjnyRak jajnikaStany Zjednoczone
-
Weill Medical College of Cornell UniversityDoris Duke Charitable FoundationJeszcze nie rekrutacjaKwestia zdrowia psychicznegoStany Zjednoczone
-
University of Texas Southwestern Medical CenterNational Institute on Minority Health and Health Disparities (NIMHD)Rejestracja na zaproszenieCukrzyca typu 2 | Stan przedcukrzycowyStany Zjednoczone
-
Kowloon Hospital, Hong KongChinese University of Hong Kong; Kwong Wah HospitalZakończonyUderzenie | Opuszczanie stopy (nabyte)Hongkong
-
The University of Texas Health Science Center,...Eunice Kennedy Shriver National Institute of Child Health and Human Development... i inni współpracownicyRekrutacyjnyStwardnienie rozsianeStany Zjednoczone